Group One Trading, L.P. Arbutus Biopharma Corp Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 59,559 shares of ABUS stock, worth $195,949. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,559
Previous 26,191 127.4%
Holding current value
$195,949
Previous $80,000 186.25%
% of portfolio
0.01%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.12 - $4.56 $104,108 - $152,158
33,368 Added 127.4%
59,559 $229,000
Q2 2024

Aug 14, 2024
SELL
$2.52 - $3.63 $100,235 - $144,386
-39,776 Reduced 60.3%
26,191 $80,000
Q1 2024

May 10, 2024
BUY
$2.26 - $2.92 $132,560 - $171,272
58,655 Added 802.17%
65,967 $170,000
Q4 2023

Feb 14, 2024
BUY
$1.69 - $2.54 $12,357 - $18,572
7,312 New
7,312 $18,000
Q3 2022

Nov 09, 2022
SELL
$1.88 - $2.88 $14,519 - $22,242
-7,723 Reduced 55.82%
6,112 $12,000
Q2 2022

Aug 11, 2022
SELL
$1.98 - $3.17 $340,453 - $545,068
-171,946 Reduced 92.55%
13,835 $37,000
Q1 2022

May 12, 2022
SELL
$2.42 - $3.98 $418,033 - $687,509
-172,741 Reduced 48.18%
185,781 $554,000
Q4 2021

Feb 11, 2022
BUY
$3.11 - $4.61 $330,583 - $490,029
106,297 Added 42.14%
358,522 $1.4 Million
Q3 2021

Nov 12, 2021
BUY
$2.65 - $4.62 $475,394 - $828,800
179,394 Added 246.32%
252,225 $1.08 Million
Q2 2021

Aug 10, 2021
SELL
$2.5 - $3.51 $129,395 - $181,670
-51,758 Reduced 41.54%
72,831 $221,000
Q1 2021

May 12, 2021
SELL
$3.14 - $4.84 $640,848 - $987,805
-204,092 Reduced 62.09%
124,589 $415,000
Q4 2020

Feb 10, 2021
BUY
$2.76 - $4.97 $704,131 - $1.27 Million
255,120 Added 346.81%
328,681 $1.17 Million
Q3 2020

Nov 12, 2020
BUY
$1.75 - $6.2 $128,731 - $456,078
73,561 New
73,561 $230,000
Q2 2020

Aug 13, 2020
SELL
$0.91 - $2.36 $4,983 - $12,923
-5,476 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$1.01 - $3.42 $5,530 - $18,727
5,476 New
5,476 $6,000
Q4 2019

Feb 10, 2020
SELL
$0.87 - $2.89 $2,731 - $9,074
-3,140 Closed
0 $0
Q3 2019

Nov 12, 2019
SELL
$1.34 - $2.4 $1,878 - $3,364
-1,402 Reduced 30.87%
3,140 $5,000
Q2 2019

Aug 09, 2019
BUY
$1.46 - $4.44 $6,631 - $20,166
4,542 New
4,542 $9,000
Q1 2019

May 13, 2019
SELL
$3.41 - $4.57 $6,073 - $8,139
-1,781 Closed
0 $0
Q4 2018

Feb 06, 2019
BUY
$3.5 - $9.66 $6,233 - $17,204
1,781 New
1,781 $7,000
Q4 2017

Feb 09, 2018
SELL
$4.45 - $7.7 $88,243 - $152,691
-19,830 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$3.4 - $7.0 $21,355 - $43,967
6,281 Added 46.36%
19,830 $123,000
Q2 2017

Aug 14, 2017
BUY
N/A
13,549
13,549 $49,000

Others Institutions Holding ABUS

# of Institutions
155
Shares Held
99.5M
Call Options Held
2.31M
Put Options Held
525K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $493M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email